We found that NIHTB-OIT scores were significantly lower for participants who had a positive AD biomarker test compared to those who had negative AD biomarker test, collapsed across available CSF Aß40/42, total tau, or phospho-tau measures and amyloid-PET measures. Here, MAPT is linked to Alzheimer disease.